Aline Betancourt

This inventor holds 6 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Sanbio, Inc., Commence Bio, Inc., Ranas, LLC. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aline Betancourt. Retrieved from https://idiyas.com/inventor/aline-betancourt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 (Patent Applications = 5)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 1.3

ph-index = 2

Forward Citations = 7(Granted Patents)

Company Filing History:

Years Active: 2016-2026

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12553033 - Medium, methods, cells and secreted factors for stem cell culture and therapy (2026-02-17),

2. 11946072 - Medium, methods, cells and secreted factors for stem cell culture and therapy (2024-04-02),

3. 11707489 - Oral delivery of therapeutic mammalian cells (2023-07-25),

4. 11046929 - Induction medium and methods for stem cell culture and therapy (2021-06-29),

5. 10273449 - Induction medium and methods for stem cell culture and therapy (2019-04-30),

6. 9321994 - Induction medium and methods for stem cell culture and therapy (2016-04-26),

Title: Aline Betancourt: Innovator in Stem Cell Therapy

Introduction

Aline Betancourt is a prominent inventor based in La Jolla, California. She has made significant contributions to the field of stem cell therapy, holding a total of 6 patents. Her work focuses on developing innovative methods and systems for enhancing the therapeutic potential of stem cells.

Latest Patents

Among her latest patents is a groundbreaking invention titled "Medium, methods, cells and secreted factors for stem cell culture and therapy." This patent describes methods and culture mediums that are useful for inducing polarization in multipotent stem cells. Additionally, it outlines the multipotent cells produced by these methods, which serve as valuable therapeutic agents. Another notable patent is "Oral delivery of therapeutic mammalian cells," which presents oral delivery systems designed to transport live mammalian cells to the intestinal tract of individuals.

Career Highlights

Aline has worked with several innovative companies, including Sanbio, Inc. and Commence Bio, Inc. Her experience in these organizations has allowed her to advance her research and contribute to the development of cutting-edge therapies.

Collaborations

Throughout her career, Aline has collaborated with esteemed colleagues such as Ruth S. Waterman and Thomas F. Isett. These partnerships have enriched her research and expanded the impact of her inventions.

Conclusion

Aline Betancourt is a trailblazer in the field of stem cell therapy, with a focus on innovative methods that enhance the therapeutic potential of stem cells. Her contributions continue to shape the future of regenerative medicine.

Profile summary based on public USPTO records.